Sedative load and anticholinergic burden among older adults in Slovenia over a decade: Potential for optimization of pharmacotherapy

Abstract This study investigates the 10-year trend in the sedative and anticholinergic burden among older adults in Slovenia, with the aim of identifying opportunities to optimize pharmacotherapy in this population. A retrospective drug utilization analysis was conducted based on a national anonymized database of dispensed prescriptions from 2009 to 2019. The study employed the sedative load model and the anticholinergic cognitive burden scale to assess the sedative and anti cholinergic burden, respectively. The findings indicate that in 2019, 45.6 % and 40.8 % of older adults (≥ 65 years) used sedative and anticholinergic medications, respectively. A high sedative load and a clinically significant anticholinergic burden were observed in a considerable proportion of older adults (13.2 % and 11.2 %, respectively, in 2019). The age-standardized prevalence of sedative load and anti-cholinergic burden significantly decreased over the 10-year study period by 5.6 % and 1.7 %, respectively (absolute difference), while the prevalence of clinically significant anticholinergic burden remained stable. Notably, the age groups 85–89 years and above 90 years had an increase in the proportion of individuals with a clinically significant anticholinergic burden over the years. These results emphasize the need for targeted interventions, particularly in the oldest age groups, to promote safe and effective medication use among older adults.

[1]  S. Hilmer,et al.  The anticholinergic burden: from research to practice , 2022, Australian prescriber.

[2]  T. Strandberg,et al.  Temporal Trends Over Two Decades in the Use of Anticholinergic Drugs Among Older Community-Dwelling People in Helsinki, Finland , 2022, Drugs & Aging.

[3]  I-Chia Chien,et al.  Trends, correlates, and disease patterns of sedative-hypnotic use among elderly persons in Taiwan , 2022, BMC Psychiatry.

[4]  C. Lunghi,et al.  Trends in benzodiazepine and alternative hypnotic use in relation with multimorbidity among older adults in Quebec, Canada , 2021, Pharmacoepidemiology and drug safety.

[5]  J. Turgeon,et al.  Quantifying Anticholinergic Burden and Sedative Load in Older Adults with Polypharmacy: A Systematic Review of Risk Scales and Models , 2021, Drugs & Aging.

[6]  R. Marioni,et al.  Increase in anticholinergic burden from 1990 to 2015: Age‐period‐cohort analysis in UK biobank , 2021, British journal of clinical pharmacology.

[7]  Y. Bao,et al.  Anticholinergic drugs and the risk of dementia: A systematic review and meta-analysis , 2021, Neuroscience & Biobehavioral Reviews.

[8]  Y. Loke,et al.  Interventions to Reduce Anticholinergic Burden in Adults Aged 65 and Older: A Systematic Review. , 2020, Journal of the American Medical Directors Association.

[9]  B. Hanratty,et al.  Adverse Outcomes of Polypharmacy in Older People: Systematic Review of Reviews. , 2020, Journal of the American Medical Directors Association.

[10]  H. Kautiainen,et al.  Temporal Trends in the Use of Anticholinergic Drugs Among Older People Living in Long-Term Care Facilities in Helsinki , 2019, Drugs & Aging.

[11]  H. Kautiainen,et al.  Fourteen-Year Trends in the Use of Psychotropic Medications, Opioids, and Other Sedatives Among Institutionalized Older People in Helsinki, Finland. , 2019, Journal of the American Medical Directors Association.

[12]  M. Lapeyre-Mestre,et al.  Trends of atropinic (anticholinergic) exposure in the elderly: a 10‐year analysis in the French EGB database , 2019, Fundamental & clinical pharmacology.

[13]  Mitja Kos,et al.  Introduction of therapeutic reference pricing in Slovenia and its economic consequences , 2018, The European Journal of Health Economics.

[14]  I. Locatelli,et al.  Clinically relevant potential drug–drug interactions among outpatients: A nationwide database study , 2017, Research in social & administrative pharmacy : RSAP.

[15]  S. Marcus,et al.  National Trends in Antidepressant, Benzodiazepine, and Other Sedative-Hypnotic Treatment of Older Adults in Psychiatric and Primary Care. , 2017, The Journal of clinical psychiatry.

[16]  M. Boustani,et al.  Association of Anticholinergic Burden with Cognitive Impairment and Health Care Utilization Among a Diverse Ambulatory Older Adult Population , 2016, Pharmacotherapy.

[17]  Christopher N. Kaufmann,et al.  Trends in prescribing of sedative‐hypnotic medications in the USA: 1993–2010 , 2016, Pharmacoepidemiology and drug safety.

[18]  T. Chen,et al.  Health Care Practitioners’ Perspectives on Deprescribing Anticholinergic and Sedative Medications in Older Adults , 2016, The Annals of pharmacotherapy.

[19]  P. Rochon,et al.  Changing Pattern of Sedative Use in Older Adults: A Population-Based Cohort Study , 2016, Drugs & Aging.

[20]  J. Bell,et al.  Eight-Year Trends in the Use of Opioids, Other Analgesics, and Psychotropic Medications Among Institutionalized Older People in Finland. , 2015, Journal of the American Medical Directors Association.

[21]  R. Kenny,et al.  Sedative load and frailty among community-dwelling population aged ≥65 years. , 2015, Journal of the American Medical Directors Association.

[22]  S. Duffull,et al.  Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review , 2015, BMC Geriatrics.

[23]  H. Aljadhey,et al.  A systematic review of hospitalization resulting from medicine‐related problems in adult patients , 2014, British journal of clinical pharmacology.

[24]  Maria C. Pruchnicki,et al.  Evaluation of anticholinergic burden of medications in older adults. , 2013, Journal of the American Pharmacists Association : JAPhA.

[25]  M. Boustani,et al.  The 2012 update to the anticholinergic cognitive burden scale , 2013 .

[26]  R. V. Vander Stichele,et al.  Systematic review of anticholinergic risk scales in older adults , 2013, European Journal of Clinical Pharmacology.

[27]  F. Blyth,et al.  High risk prescribing in older adults: prevalence, clinical and economic implications and potential for intervention at the population level , 2013, BMC Public Health.

[28]  R. Sulkava,et al.  Sedative Load Among Community-Dwelling People Aged 75 Years or Older: Association With Balance and Mobility , 2012, Journal of clinical psychopharmacology.

[29]  R. Sulkava,et al.  Sedative Load among Community-Dwelling People Aged 75 Years and Older , 2011, Drugs & aging.

[30]  C. Goodman,et al.  Sedative load of medications prescribed for older people with dementia in care homes , 2011, BMC geriatrics.

[31]  Cornelius Katona,et al.  Anticholinergic Medication Use and Cognitive Impairment in the Older Population: The Medical Research Council Cognitive Function and Ageing Study , 2011, Journal of the American Geriatrics Society.

[32]  M. Boustani,et al.  Impact of anticholinergics on the aging brain: a review and practical application , 2008 .

[33]  S. Kivelä,et al.  A model to classify the sedative load of drugs , 2003, International journal of geriatric psychiatry.

[34]  THE WORLD HEALTH ORGANIZATION , 1954 .

[35]  J. Bell,et al.  Anticholinergic and sedative medicines - prescribing considerations for people with dementia. , 2012, Australian family physician.